Regional difference in inflammatory response to LPS-injection in the brain: Role of microglia cell density

Journal of Neuroimmunology

Volumn 238, Issue 1-2, 2011, Pages 44-51

  Pintado, Cristina ^a,b   Revilla, Elisa ^a   Vizuete, María L ^a,b,c   Jiménez, Sebastián ^a,b,c   García Cuervo, Luisa ^a,b,c   Vitorica, Javier ^a,b,c   Ruano, Diego ^a,b,c   Castaño, Angélica ^a,b,c  

^a UNIVERSITY OF SEVILLE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Inflammation; Microglia density; Neurodegeneration; Striatum; Substantia nigra

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GLUTAMATE DECARBOXYLASE 65; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; S METHYLPSEUDOTHIOUREA; THIOUREA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL ACTIVATION; CELL DENSITY; CONTROLLED STUDY; CORPUS STRIATUM; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DOWN REGULATION; GLIA CELL; INFLAMMATION; MALE; MICROGLIA; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SUBSTANTIA NIGRA; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL COUNT; CELL LINE, TRANSFORMED; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMIDAZOLES; INTERLEUKIN-10; ISOTHIURONIUM; LIPOPOLYSACCHARIDES; MALE; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; PYRIDINES; RATS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052864979     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.06.017     Document Type: Article

References (47)

1. Arimoto T., Choi D.-Y., Lu X., Liu M., Nguyen X., Zheng N., Stewart C.A., Kim H.-C., Bing G. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol. Aging 2007, 28:894-906.
2. Bachis A., Colangelo A.M., Vicini S., Doe P.P., De Bernardi M.A., Brooker G., et al. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J. Neurosci. 2001, 21(9):3104-3112.
3. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 1992, 587(2):250-256.
4. Brosnan C.F., Battistini L., Raine C.S., Dickson D.W., Casadevall A., Lee S.C. Reactive nitrogen intermediates in human neuropathology: an overview. Dev. Neurosci. 1994, 16(3-4):152-161.
5. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 1992, 149(8):2736-2741.
6. Choi S.H., Joe E.H., Kim S.U., Jin B.K. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J. Neurosci. 2003, 23(13):5877-5886.
7. Dawson V.L., Brahmbhatt H.P., Mong J.A., Dawson T.M. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology 1994, 33(11):1425-1430.
8. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993, 71(1):75-83.
9. Dietrich W.D., Busto R., Bethea J.R. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp. Neurol. 1999, 158(2):444-450.
10. Djukic M., Mildner A., Schmidt H., Czesnik D., Bruck W., Priller J., Nau R., Prinz M. Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 2006, 129:2394-2403.
11. Dutta G., Zhang P., Liu B. The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery. Fundam. Clin. Pharmacol. 2008, 22:453-464.
12. Espey M.G., Chernyshev O.N., Reinhard J.F., Namboodiri M.A., Colton C.A. Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport 1997, 8(2):431-434.
13. Espinosa-Oliva A.M., de Pablos R.M., Villarán R.F., Argüelles S., Venero J.L., Machado A., Cano J. Stress is critical for LPS-induced activation of microgliaand damage in the rat hippocampus. Neurobiol. Aging 2011, 32(1):85-102.
14. Gavilán M.P., Revilla E., Pintado C., Castaño A., Vizuete M.L., Moreno-González I., Baglietto-Vargas D., Sánchez-Varo R., Vitorica J., Gutiérrez A., Ruano D. Molecular and cellular characterization of the age-related neuroinflammatory processes occurring in normal rat hippocampus: potential relation with the loss of somatostatin GABAergic neurons. J. Neurochem. 2007, 103:984-996.
15. Gavilán M.P., Castaño A., Torres M., Revilla E., Caballero C., Jiménez S., García-Martínez A., Parrado J., Vitorica J., Ruano D. Age-related increase in the immunoproteasome content in rat hippocampus: molecular and functional aspects. J. Neurochem. 2009, 108:260-270.
16. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10(11):1387-1394.
17. Herrera A.J., Castaño A., Venero J.L., Cano J., Machado A. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol. Dis. 2000, 7:429-447.
18. Horiuchi T., Mitoma H., Harashima S., Tsukamoto H., Shimoda T. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology 2010, 49(7):1215-1228.
19. Hu S., Chao C.C., Ehrlich L.C., Sheng W.S., Sutton R.L., Rockswold G.L., et al. Inhibition of microglial cell RANTES production by IL-10 and TGF-beta. J. Leukoc. Biol. 1999, 65(6):815-821.
20. Ji K.A., Eu M.Y., Kang S.H., Gwag B.J., Jou I., Joe E.H. Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex. Glia 2008, 56:1039-1047.
21. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 2000, 20:6309-6316.
22. Knoblach S.M., Faden A.I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp. Neurol. 1998, 153(1):143-151.
23. Kong L.Y., McMillian M.K., Maronpot R., Hong J.S. Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microglia-enriched or astrocyte-enriched cultures. Brain Res. 1996, 729:102-109.
24. Kremlev S.G., Palmer C. Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J. Neuroimmunol. 2005, 162(1-2):71-80.
25. Lawson L.J., Perry V.H., Dri P., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39:151-170.
26. Ledeboer A., Breve J.J., Poole S., Tilders F.J., Van Dam A.M. Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia 2000, 30(2):134-142.
27. Lee S.C., Liu W., Dickson D.W., Brosnan C.F., Berman J.W. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 1993, 150(7):2659-2667.
28. Lee Y.B., Nagai A., Kim S.U. Cytokines, chemokines, andcytokine receptors in human microglia. J. Neurosci. Res. 2002, 69:94-103.
29. Liu B., Du L., Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J. Pharmacol. Exp. Ther. 2000, 293:607-617.
30. Lodge P.A., Sriram S. Regulation of microglial activation by TGF-beta, IL-10, and CSF-1. J. Leukoc. Biol. 1996, 60(4):502-508.
31. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
32. Lu X., Bing G., Hagg T. Naloxane prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats. Neuroscience 2000, 97(2):285-291.
33. Matsuo M., Hamasaki Y., Fujiyama F., Miyazaki S. Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures. Brain Res. 1995, 685(1-2):201-204.
34. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 1998, 54(1):99-125.
35. Mizuno T., Sawada M., Marunouchi T., Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 1994, 205:1907-1915.
36. Molina-Holgado F., Grencis R., Rothwell N.J. Actions of exogenous and endogenous IL-10 on glial responses to bacterial LPS/cytokines. Glia 2001, 33(2):97-106.
37. Molina-Holgado E., Vela J.M., Arevalo-Martín A., Guaza C. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur. J. Neurosci. 2001, 13:493-502.
38. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Orlando, FL. 2nd ed.
39. Righi M., Mori L., De Libero G., Sironi M., Biondi A., Mantovani A., Donini S.D., Ricciardi-Castagnoli P. Monokine production by microglial cell clones. Eur. J. Immunol. 1989, 19:1443-1448.
40. Ross H.R., Romrell L.J., Kaye G.I. Histology: a Test and Atlas 1995, 282. Williams & Wilkins, Baltimore.
41. Ruano D., Revilla E., Gavilán M.P., Vizuete M.L., Pintado C., Vitorica J., Castaño A. Role of p38 and iNOS in the in vivo dopaminergic cells degeneration induced by inflammatory processes after LPS injection. Neuroscience 2006, 140:1157-1168.
42. Sawada M., Suzumura A., Hosoya H., Marunouchi T., Nagatsu T. Interleukin-10 inhibits both production of cytokines and expressionof cytokine receptors in microglia. J. Neurochem. 1999, 72(4):1466-1471.
43. Seo D.R., Kim K.Y., Lee Y.B. Interleukin-10 expression in lipopolysaccharide-activated microglia is mediated by extracellular ATP in an autocrine fashion. Neuroreport 2004, 15:1157-1161.
44. Simard A.R., Rivest S. Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 2004, 18:998-1000.
45. Tomas-Camardiel M., Rite I., Herrera A.J., de Pablos R.M., Cano J., Machado A., Venero J.L. Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol. Dis. 2004, 16:190-201.
46. Vizuete M.L., Merino M., Venero J.L., Santiago M., Cano J., Machado A. Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra. J. Neurochem. 2000, 75:540-552.
47. Williams K., Dooley N., Ulvestad E., Becher B., Antel J.P. IL-10 production by adult human derived microglial cells. Neurochem. Int. 1996, 29:55-64.